BMRN Financials
Biomarin Pharmaceutical Inc - Financial statements & key metrics
Stock Price
$65.75
Market Cap
$10.63B
P/E Ratio
21.5
EPS
$2.69
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$2.85B
Gross Profit
-
Operating Income
-
Net Income
$426.86M
EPS (Diluted)
$2.21
Balance Sheet Highlights
Total Assets
$6.99B
Total Liabilities
$1.33B
Shareholders Equity
-
Cash & Equivalents
$942.84M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$572.84M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-6.0%
Net Margin
16.8%
ROE
9.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is BMRN revenue?
BMRN's most recent quarterly revenue was $2.85B. Annual revenue can be calculated by summing the four most recent quarters.
Is BMRN profitable?
BMRN reported a profit of $426.86M in the most recent quarter. The net profit margin is 16.8%.
What is BMRN market cap?
BMRN has a market capitalization of $10.63B, making it a large-cap stock.
Does BMRN have debt?
View BMRN's balance sheet for debt information.
What is BMRN cash flow?
Cash flow data is available in the full financial statements.